IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IRADIMED CORPORATION on October 30, 2015. The filing serves to announce the Company's financial results for the third quarter ended September 30, 2015.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the source text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms the issuance of a press release containing the third-quarter results.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. The document explicitly states that the information in Item 2.02 and the attached exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated October 30, 2015) for specific third-quarter financial figures.
- Verify the Company's liquidity position and debt levels in the full press release or subsequent 10-Q filing.
- Confirm any year-over-year growth rates or margin changes detailed in the omitted press release.
- Check for any forward-looking statements or risk factors disclosed in the full press release text.